Digital Health and Outcomes: Where's the Evidence?
Saturday, March 12
3:30PM - 4:30PM
110 E 2nd St
Despite thousands of apps and devices emerging in the digital health universe, the sad fact is that most have no demonstrable outcomes—they don't clearly improve anyone's health, and they haven't proved they can reduce costs—ultimately leading to a lack of viability. It's time for the sector to mature and start demonstrating its value. This panel, moderated by BuzzFeed's Stephanie Lee, will explore how digital health companies can use clinical evidence to succeed through the lens of a company that has commercialized its outcomes (Omada Health), a company that validates emerging products (Evidation Health), and an investor that evaluates hundreds of companies each year (Rock Health).
Christine leads product management and development at Evidation Health. Previously, Christine co-founded and led The Activity Exchange, an insight and personalization platform that helps healthcare...Show the rest
Christine leads product management and development at Evidation Health. Previously, Christine co-founded and led The Activity Exchange, an insight and personalization platform that helps healthcare companies deliver the right digital interventions and incentives to consumers to help them achieve sustainable behavior change. Prior to her work in healthcare, Christine was the co-founder and Chief Operating Officer of Sense Networks, developers of the first machine learning platform for mobile phone activity data (exited to YP.com). She has also held roles at 3iGroup (Paris), Microsoft XBOX and co-founded Chicago-based Channel IQ, a product analytics platform. Christine has a BA from the University of Washington and an MBA from HEC Paris.Hide the rest
Malay is the Co-founder and Managing Partner of Ensemble Labs and serves as an advisor to a number of leading health tech companies. Previously, Malay led Rock Health as its CEO and Managing Direct...Show the rest
Malay is the Co-founder and Managing Partner of Ensemble Labs and serves as an advisor to a number of leading health tech companies. Previously, Malay led Rock Health as its CEO and Managing Director, where he supported its portfolio companies, raised its first committed venture fund, and originated investments in Benchling, Collective Health, Evidation, Health IQ, Honor, and Stride Health, amongst others. Malay's research and work in health tech has been cited in the The New York Times, Financial Times, CNBC, NPR, Bloomberg, USA Today, Inc. and The Information.Hide the rest
Chief Commercial Officer
Mike is a commercial leader who has worked with companies in every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand w...Show the rest
Mike is a commercial leader who has worked with companies in every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand with current leaders in the healthcare and benefits world. He is committed to expanding Omada’s leadership in the new generation of digital behavioral medicine providers, focused on evidence-based digital health programs for specific, complex diseases. Mike’s areas of responsibility at Omada include Sales, Strategy & Business Development, Government Affairs, Clinical Quality, and Clinical Evidence/Publications. Mike joined Omada from biotechnology leader Gilead Sciences, where he spent 6 years as Senior Director of Commercial Strategy, with experience in new product development, M&A, and marketing. Mike was previously with the healthcare practice at McKinsey & Company where he worked with healthcare clients in biotechnology/pharma, medical devices, health systems, and global health. Mike has an MBA from Stanford Business School as well as an MSc in Health Services Research from Stanford Medical School.Hide the rest
Sr Technology Reporter
Stephanie Lee is a senior technology reporter for BuzzFeed News in San Francisco, where she covers the technology side of science and health.